HuMedix Holds "Elravie Russia Academy"

Huons Group's HuMedix held an on-site communication meeting, inviting its Russian partner company and local medical professionals, ahead of the launch of its hyaluronic acid (HA) filler products in Russia.

On the previous day (the 6th), HuMedix hosted the "Elravie Russia Academy," inviting executives and employees from its distribution partner Bella-Systech, as well as key local medical professionals from Russia, the company announced on the 7th.

To commemorate the upcoming entry of its HA fillers into the Russian market next year, HuMedix organized this event to strengthen its partnership and to showcase the superior competitiveness of its products to local medical professionals.

On the morning of the event, the visiting group attended a theoretical lecture and live demonstration of the "Elravie Premier Filler" at Gangnam Beauty Bar Plastic Surgery Clinic. Kim Eunyeon, the clinic's director and the event's speaker, delivered a lecture on "the rheological properties and sterilization process of Elravie Premier Filler." In addition, she demonstrated procedures for mid and lower facial improvement, sharing expertise on safe and effective techniques.

After attending the academy, the visitors toured the HuMedix Gwacheon Research Center and the headquarters' promotional hall, where they learned about the company's advanced technology and history.

Bella-Systech is a distribution company that supplies a variety of products-including aesthetic fillers, skin boosters, and medical devices-to medical institutions in Russia and the Commonwealth of Independent States (CIS). In partnership with Bella-Systech, HuMedix plans to begin full-scale sales of its high-quality HA fillers in the Russian market starting next year. The company also aims to expand its export volume and reach in Russia and Central Asia.

Kang Minjong, CEO of HuMedix, stated, "Through this on-site meeting, we had the opportunity to share HuMedix's technological capabilities and global vision, and to build trust. Moving forward, we will continue to strengthen our credibility in the global market through ongoing exchanges with international medical professionals."

This content was produced with the assistance of AI translation services.